Business in the Burbs

Acorda releases new data on drug

September

Acorda Therapeutics Inc., a biotech company in Hawthorne, said that new data shows promising results for a multiple sclerosis drug that is being tested on patients.

A clinical trial showed that patients taking the medication, known as Fampridine-SR, showed greater improvements in leg strength than those aking a placebo, according to Acorda.

Data released in June showed that nearly 43 percent of the patients taking the medication walked faster compared with 9.3 percent of the patients taking a placebo. If the drug receives regulatory approval, it could one day make walking easier for the multiple sclerosis victims who deal with mobility problems.

This entry was posted on Monday, September 22nd, 2008 at 10:47 am by Jay Loomis. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.